Co-Diagnostics Raises $2.67M via Warrant Inducement, Issues 3.4M New Warrants at $1.56
CODX sits 31% above its 52-week low of $1.26 on light trading volume (0.1× avg).
Summary
Co-Diagnostics raised $2.67 million by inducing early exercise of existing warrants, issuing 3.4 million new warrants at $1.56 in return — a lifeline for the cash-strapped diagnostics company, but at the cost of substantial future dilution.
Key Events · Financing and Capital Events · CODX
-
Warrant Inducement Raises $2.67M
Holders exercised 1,702,362 existing warrants at $1.571 per share, providing approximately $2.67 million in gross proceeds before fees.
-
3.4M New Warrants Issued at $1.56
As inducement, the company issued 3,404,724 new warrants with a $1.56 exercise price — double the shares exercised — exercisable only after stockholder approval, with a five-year term from approval.
-
Potential Dilution of ~49%
If all new warrants are exercised, outstanding shares would increase by approximately 3.4 million from the post-transaction base of 6.98 million, representing roughly 49% dilution.
-
Stockholder Approval Required
The new warrants cannot be exercised until Nasdaq-compliant stockholder approval is obtained; the company must hold a vote within 90 days and every 90 days thereafter until approval.
Analysis · CODX · Industrial Applications And Services
Facing a going-concern warning and a market cap of just $8.2 million, Co-Diagnostics persuaded holders of 1.7 million existing warrants to exercise early at $1.571, injecting $2.67 million in cash. In return, the company issued 3.4 million new warrants with a $1.56 strike — double the shares, at a slightly lower price. These new warrants cannot be exercised until shareholders approve, creating a near-term overhang. The cash buys time, but the potential dilution is significant: if all new warrants are exercised, outstanding shares would rise by roughly 49% from the post-transaction base of 6.98 million shares.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $1.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.2M. The 52-week trading range was $1.26 to $46.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.